A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer

Autor: Pallis, Athanasios G., Agelidou, Athina, Agelaki, Sofia, Varthalitis, Ioannis, Pavlakou, Georgia, Gerogianni, Aleka, Papakotoulas, Pavlos, Rapti, Ageliki, Chandrinos, Vassilis, Christophyllakis, Charalampos, Georgoulias, Vassilis
Zdroj: In Lung Cancer 2009 65(2):187-191
Databáze: ScienceDirect